107 related articles for article (PubMed ID: 8046598)
1. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
[TBL] [Abstract][Full Text] [Related]
2. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
3. [Clinical pharmacokinetics of vinca alkaloids].
Rahmani R; Samak R; Bore P; Cano JP
Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
[TBL] [Abstract][Full Text] [Related]
6. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
Levêque D; Jehl F; Quoix E; Monteil H
Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Krikorian A; Breillout F
Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of Navelbine.
Krikorian A; Rahmani R; Bromet M; Bore P; Cano JP
Semin Oncol; 1989 Apr; 16(2 Suppl 4):21-5. PubMed ID: 2652317
[No Abstract] [Full Text] [Related]
13. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
[TBL] [Abstract][Full Text] [Related]
14. Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids.
Schlaifer D; Cooper MR; Attal M; Rousseau A; Pris J; Laurent G; Myers CE
Leukemia; 1994 Apr; 8(4):668-71. PubMed ID: 8152263
[TBL] [Abstract][Full Text] [Related]
15. Biochemical effects of Navelbine on tubulin and associated proteins.
Fellous A; Ohayon R; Vacassin T; Binet S; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):9-14. PubMed ID: 2496470
[TBL] [Abstract][Full Text] [Related]
16. In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.
Binet S; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):5-8. PubMed ID: 2652320
[TBL] [Abstract][Full Text] [Related]
17. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
Mathé G; Reizenstein P
Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine.
Zhou XJ; Martin M; Placidi M; Cano JP; Rahmani R
Eur J Drug Metab Pharmacokinet; 1990; 15(4):323-32. PubMed ID: 2088769
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.
Debal V; Allam N; Morjani H; Millot JM; Braguer D; Breillout F; Manfait M
Br J Cancer; 1994 Dec; 70(6):1118-25. PubMed ID: 7981063
[TBL] [Abstract][Full Text] [Related]
20. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
